| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/13/2011 | WO2011005250A1 Formulations of 6- (5-chloro-2-pyridyl) - 5- [ (4-methyl-1-piperazinyl) carbonyloxy] - 7-0x0-6, 7- dihydro- 5h- phyrrolo [3, 4-b] pyrazine |
| 01/13/2011 | WO2011005142A1 Method for treating liver diseases of various origins |
| 01/13/2011 | WO2011005119A1 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| 01/13/2011 | WO2011005113A1 Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition |
| 01/13/2011 | WO2011005052A2 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same |
| 01/13/2011 | WO2011004936A1 Method for producing bioactive cellulose membrane from skin horny layer of ascidiacea and bioactive cellulose membrane obtained thereby |
| 01/13/2011 | WO2011004910A1 Glycyrrhizin as restorative agent for antimicrobial peptide production ability |
| 01/13/2011 | WO2011004882A1 Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement |
| 01/13/2011 | WO2011004799A1 Tablet having hollow structure |
| 01/13/2011 | WO2011004620A1 Cytoprotective agent |
| 01/13/2011 | WO2011004610A1 Azabicyclo compound and salt thereof |
| 01/13/2011 | WO2011004604A1 Diphenyl sulfide derivatives and medicines containing same as active ingredient |
| 01/13/2011 | WO2011004552A1 Water-soluble drug carrier and process for production thereof |
| 01/13/2011 | WO2011004392A1 Crystalline form of prasugrel hydrobromide, preparation and application thereof |
| 01/13/2011 | WO2011004325A1 Pharmaceutical compositions and therapeutic methods employing a combination of a manganese complex compound and a non-manganese complex form of the compound |
| 01/13/2011 | WO2011004323A1 New inhibitors of proline racemase enzymes |
| 01/13/2011 | WO2011004282A2 Novel polymorphic form of teriflunomide salts |
| 01/13/2011 | WO2011004276A1 Hepatitis c virus inhibitors |
| 01/13/2011 | WO2011004196A1 Cyclic triazo sodium channel blockers |
| 01/13/2011 | WO2011004194A1 Method of treating age related disorders |
| 01/13/2011 | WO2011004166A1 Combined preparation for use as a medicament |
| 01/13/2011 | WO2011004132A1 Novel hsp90-inhibiting indole derivatives, compositions containing said derivatives, and use thereof |
| 01/13/2011 | WO2011004117A1 Method and pharmaceutical compositions for trans-buccal mucosa treatment of postprandial hyperglycaemia in type ii diabetes |
| 01/13/2011 | WO2011004038A1 Use of l-carnitine for preventing inflammatory cardiac damage associated with arterial hypertension |
| 01/13/2011 | WO2011004018A1 Substituted pyrrolidinone as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use |
| 01/13/2011 | WO2011004017A1 1-(6 members azo-heterocyclic)-pyrrolin-2-one compounds as inhibitors of hepatitis c ns5b polymerase, the pharmaceutical composition thereof and their therapeutic use |
| 01/13/2011 | WO2011003992A1 A crystalline form of posaconazole |
| 01/13/2011 | WO2011003938A1 Salts of rasagiline and pharmaceutical preparations thereof |
| 01/13/2011 | WO2011003876A1 New antiviral compounds useful for the treatment or the prevention of epidemic keratoconjonctivitis |
| 01/13/2011 | WO2011003858A2 Pharmaceutical compositions and solid forms |
| 01/13/2011 | WO2011003737A1 USE OF BENZYDAMINE IN THE TREATMENT OF p40-DEPENDENT DISEASES |
| 01/13/2011 | WO2011003626A1 INDUCTION OF α-HELIX CONFORMATIONS IN PROTEINS AND PEPTIDES |
| 01/13/2011 | WO2011003604A1 Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof |
| 01/13/2011 | WO2011003430A1 Liquid pharmaceutical form of alkylphosphocholine and method of preparing same |
| 01/13/2011 | WO2011003418A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 01/13/2011 | WO2011003365A1 Histone deacetylase inhibitors with branched structure synthesized through click chemistry |
| 01/13/2011 | WO2011003362A1 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof |
| 01/13/2011 | WO2011003284A1 Compound and preparation method and use thereof |
| 01/13/2011 | WO2011003226A1 Pharmaceutical composition for treating depression and preparative method and use thereof |
| 01/13/2011 | WO2011003223A1 Pharmaceutical composition for treating or preventing angina or myocardial infarction induced by myocardial ischemia |
| 01/13/2011 | WO2011003194A1 Oncolytic viruses and methods for treating neoplastic disorders |
| 01/13/2011 | WO2011003191A1 Compositions and methods for enhancing virus efficacy |
| 01/13/2011 | WO2011003129A1 Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers |
| 01/13/2011 | WO2010135714A3 Methods for modulating adipocyte expression using microrna compositions |
| 01/13/2011 | WO2010135703A3 Endoxifen methods and compositions in the treatment of mammalian diseases |
| 01/13/2011 | WO2010135170A3 Nitrile derivatives and their pharmaceutical use and compositions |
| 01/13/2011 | WO2010133906A3 Use of specific chelating polymers in medicaments for the treatment of inflammatory bowel disease |
| 01/13/2011 | WO2010132547A3 Oxaza heterocyclic compounds for phototherapy |
| 01/13/2011 | WO2010132047A8 Guanosine/gmp gels and uses thereof |
| 01/13/2011 | WO2010129708A3 Methods and compositions related to the regulation of goblet cell differentiation, mucus production and mucus secretion |
| 01/13/2011 | WO2010129515A8 Modulation of the tgf-beta and pi3k/akt pathways in the diagnosis and treatment of squamous cell carcinoma |
| 01/13/2011 | WO2010128525A3 A formulation of ivabradine for treating the cardiovascular disease |
| 01/13/2011 | WO2010128346A3 Rosuvastatin manganse, copper, iron and zinc salts with high photochemical stability |
| 01/13/2011 | WO2010120389A3 Polymeric drug delivery systems and processes for producing such systems |
| 01/13/2011 | WO2010118309A3 Inhibitors of stat3 and uses thereof |
| 01/13/2011 | WO2010116328A3 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines as adp receptor antagonists |
| 01/13/2011 | WO2010115252A9 PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-α MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES |
| 01/13/2011 | WO2010111171A3 Enhanced treatments to kill or debilitate pathogenic microorganisms of a mammalian body |
| 01/13/2011 | WO2010110993A3 Methods and compositions for the treatment of cancer |
| 01/13/2011 | WO2010107866A3 Catecholamine derivatives for obesity and neurological disorders |
| 01/13/2011 | WO2010107807A3 Compounds for treating inflammation and pain |
| 01/13/2011 | WO2010107794A3 Compositions and methods for delivering an agent to a wound |
| 01/13/2011 | WO2010107791A4 Pyrazinoisoquinoline compounds |
| 01/13/2011 | WO2010102216A3 Enhancing coagulation or reducing fibrinolysis |
| 01/13/2011 | WO2010102214A3 Method and composition for modulating canonical wnt pathway using folate and inositol |
| 01/13/2011 | WO2010102120A9 Methods and compositions to diagnose pain |
| 01/13/2011 | WO2010102095A3 Kinase protein binding inhibitors |
| 01/13/2011 | WO2010102031A3 Methods for treating ocular inflammatory diseases |
| 01/13/2011 | WO2010101964A3 Methods and compositions useful in treating cancer and reducing wnt mediated effects in a cell |
| 01/13/2011 | WO2010101888A3 Methods and compositions for treatment of tumor metastasis |
| 01/13/2011 | WO2010101649A3 Sigma 1 receptor inhibition as a novel therapeutical approach against hepatitis c virus infection |
| 01/13/2011 | WO2010099542A3 Formulations of atp and analogas of atp |
| 01/13/2011 | WO2010099169A3 A novel in vitro hiv-1 latency model for screening reactivation agents of hiv-1 |
| 01/13/2011 | WO2010098843A3 Peptoid oligomers, pharmaceutical compositions and methods of using the same |
| 01/13/2011 | WO2010096466A9 Methods and compositions for inhibiting cellular proliferation and surgical adhesion |
| 01/13/2011 | WO2010096384A3 Fused benzazepines as neuronal nicotinic acetylcholine receptor ligands |
| 01/13/2011 | WO2010096201A3 Synthesis of ara-2'-o-methyl-nucleosides, corresponding phosphoramidites and oligonucleotides incorporating novel modifications for biological application in therapeutics, diagnostics, g- tetrad forming oligonucleotides and aptamers |
| 01/13/2011 | WO2010089105A3 Moisture-activated granulation process |
| 01/13/2011 | WO2010077894A3 Methods of inhibiting quiescent tumor proliferation |
| 01/13/2011 | WO2010077101A4 Novel thiazolidinedione derivative and use thereof |
| 01/13/2011 | WO2010075298A3 An implantable composite comprising a tacky biocompatible polymer film and a releasable bioactive agent |
| 01/13/2011 | WO2010056633A8 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 01/13/2011 | WO2010046780A3 Anti viral compounds |
| 01/13/2011 | WO2010020896A3 Substituted imidazole combinations |
| 01/13/2011 | WO2010014943A3 Methionine analogs and methods of using same |
| 01/13/2011 | WO2009153634A8 A transmucosal delivery system |
| 01/13/2011 | WO2009061482A3 Anesthetic composition, formulation and method of use |
| 01/13/2011 | US20110010784 Insulin-like gene of prawns and uses thereof |
| 01/13/2011 | US20110009955 Compounds and method for coating surfaces in a hemocompatible manner |
| 01/13/2011 | US20110009831 Antimicrobial coating for dermally invasive devices |
| 01/13/2011 | US20110009631 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009496 Resveratrol formulations |
| 01/13/2011 | US20110009495 Inhibition of the Survival of Bone Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 01/13/2011 | US20110009494 Inhibition of the Survival of Pancreatic Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 01/13/2011 | US20110009492 ß-PHENYLETHYLIDENEHYDRAZINE DERIVATIVES |
| 01/13/2011 | US20110009491 Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 01/13/2011 | US20110009490 Preparation of the formaurindikarboxyl acid base and its derivations and use |
| 01/13/2011 | US20110009489 Cosmetic composition comprising vitamin u as active ingredient for healing wounds and reducing wrinkles |
| 01/13/2011 | US20110009488 Lipoxin A4 Protection for Cornea Endothelial Cells |